Common use of Efficacy Clause in Contracts

Efficacy. When tested against Pseudomonas aeruginosa and Staphylococcus aureus in 2 hours achieves at least a 4.0 log reduction at time zero and a log reduction of 3.0 throughout the shelf life. Reference WI-8.2.4-2.017. • Maintains antimicrobial activity when tested as demonstrated by a 3 day plate to plate CZOI efficacy test against Pseudomonas aeruginosa and Staphylococcus aureus, where a CZ0I of at least 3 mm is maintained. Reference WI-8.2.4-2.034.

Efficacy. When tested against Pseudomonas aeruginosa and Staphylococcus aureus in 2 hours 30 minutes achieves at least a 4.0 log reduction at time zero and a log reduction of 3.0 throughout the shelf life. Reference WI-8.2.4-2.0172.033. • Maintains antimicrobial activity when tested as demonstrated by a 3 day plate to plate CZOI efficacy test against Pseudomonas aeruginosa and Staphylococcus aureus, where a CZ0I CZOI of at least 3 mm is maintained. Reference WI-8.2.4-2.034.

Efficacy. When tested against Pseudomonas aeruginosa and Staphylococcus aureus in 2 hours 30 minutes achieves at least a 4.0 log reduction at time zero and a log reduction of 3.0 throughout the shelf life. Reference WI-8.2.4-2.0172.033. • Maintains antimicrobial activity when tested as demonstrated by a 3 7 day plate to plate CZOI efficacy test against Pseudomonas aeruginosa and Staphylococcus aureus, where a CZ0I CZOI of at least 3 mm is maintained. Reference WI-8.2.4-2.034.

Efficacy. When tested against Pseudomonas aeruginosa and Staphylococcus aureus in 2 4 hours achieves at least a 4.0 log reduction at time zero and a log reduction of 3.0 throughout the shelf life. Reference WI-8.2.4-2.0172.016. • Maintains antimicrobial activity when tested as demonstrated by a 3 7 day plate to plate CZOI efficacy test against Pseudomonas aeruginosa and Staphylococcus aureus, where a CZ0I zone of at least 3 mm inhibition is maintainedmaintained on day 7. Reference WI-8.2.4-2.0342.013.

Efficacy. When tested against Pseudomonas aeruginosa and Staphylococcus aureus in 2 hours achieves at least a 4.0 log reduction at time zero and a log reduction of 3.0 throughout the shelf life. Reference WI-8.2.4-2.017. • Maintains antimicrobial activity when tested as demonstrated by a 3 day plate to plate CZOI efficacy test against Pseudomonas aeruginosa and Staphylococcus aureus, where a CZ0I CZOI of at least 3 mm is maintained. Reference WI-8.2.4-2.034.